Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. cellular & molecular immunology 
3. research article 
4. article
Show authors
•  Research Article
•  Published: 07 April 2014


α1-antitrypsin increases
interleukin-1 receptor
antagonist production during
pancreatic islet graft
transplantation
•  Avishag Abecassis1 na1,
•  Ronen Schuster1 na1,
•  Galit Shahaf1,
•  Eyal Ozeri1,
•  Ross Green1,
•  David E Ochayon1,
•  Peleg Rider1 &
•  …
•  Eli C Lewis
1 
Cellular & Molecular Immunology volume 11, pages 377–386
(2014)Cite this article
•  1311 Accesses
•  43 Citations
•  Metrics details
Abstract
Although islet transplantation for individuals with type 1 diabetes
has been shown to yield superior blood glucose control, it remains
inadequate for long-term control. This is partly due to islet injuries
and stresses that can lead to beta cell loss. Inhibition of excess IL-1β
activity might minimize islet injuries, thus preserving function. The
IL-1 receptor antagonist (IL-1Ra), an endogenous inhibitor of IL-1β,
protects islets from cytokine-induced necrosis and apoptosis.


Therefore, an imbalance between IL-1β and IL-1Ra might influence
the courses of allogeneic and autoimmune responses to islets. Our
group previously demonstrated that the circulating serine-protease
inhibitor human alpha-1-antitrypsin (hAAT), the levels of which
increase in circulation during acute-phase immune responses,
exhibits anti-inflammatory and islet-protective properties, as well as
immunomodulatory activity. In the present study, we sought to
determine whether the pancreatic islet allograft-protective activity
of hAAT was mediated by IL-1Ra induction. Our results
demonstrated that hAAT led to a 2.04-fold increase in IL-1Ra
expression in stimulated macrophages and that hAAT-pre-treated
islet grafts exhibited a 4.851-fold increase in IL-1Ra transcript
levels, which were associated with a moderate inflammatory
profile. Unexpectedly, islets that were isolated from IL-1Ra-
knockout mice and pre-treated with hAAT before grafting into wild-
type mice yielded an increase in intragraft IL-1Ra expression that
was presumably derived from infiltrating host cells, albeit in the
absence of hAAT treatment of the host. Indeed, hAAT-pre-treated
islets generated hAAT-free conditioned medium that could induce
IL-1Ra production in cultured macrophages. Finally, we
demonstrated that hAAT promoted a distinct phosphorylation and
nuclear translocation pattern for p65, a key transcription factor
required for IL-1Ra expression.
 Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
 Access through your institution
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue


Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support
Figure 1
[image]
Figure 2
[image]
Figure 3
[image]
Figure 4
[image]
Figure 5
[image]
Figure 6
[image]
Similar content being viewed by others
[image]
Tipping-point transition from transient to persistent
inflammation in pancreatic islets


Article Open access 12 September 2024
[image]
Biological hypoxia in pre-transplant human
pancreatic islets induces transplant failure in diabetic
mice
Article Open access 30 May 2024
[image]
Encapsulated islet transplantation
Article 24 September 2024
References
1. Eizirik DL, Mandrup-Poulsen T . A choice of death—the
signal-transduction of immune-mediated beta-cell apoptosis.
Diabetologia 2001; 44: 2115–2133.
Article  CAS  Google Scholar 
2. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper
DK . Rapid loss of intraportally transplanted islets: an
overview of pathophysiology and preventive strategies.
Xenotransplantation 2007; 14: 288–297.
Article  Google Scholar 
3. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA,
Svenson M, Nielsen JH . Affinity-purified human interleukin I
is cytotoxic to isolated islets of Langerhans. Diabetologia 1986;
29: 63–67.
Article  CAS  Google Scholar 
4. van Belle TL, Coppieters KT, von Herrath MG . Type 1
diabetes: etiology, immunology, and therapeutic strategies.
Physiol Rev 2011; 91: 79–118.


Article  CAS  Google Scholar 
5. Filippi CM, von Herrath MG . Islet beta-cell death—fuel to
sustain autoimmunity? Immunity 2007; 27: 183–185.
Article  CAS  Google Scholar 
6. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C,
Nonaka K . Mouse islet cell lysis mediated by interleukin-1-
induced Fas. Diabetologia 1996; 39: 1306–1312.
Article  CAS  Google Scholar 
7. Suarez-Pinzon WL, Power RF, Rabinovitch A . Fas ligand-
mediated mechanisms are involved in autoimmune
destruction of islet beta cells in non-obese diabetic mice.
Diabetologia 2000; 43: 1149–1156.
Article  CAS  Google Scholar 
8. Ylipaasto P, Smura T, Gopalacharyulu P, Paananen A,
Seppanen-Laakso T, Kaijalainen S et al. Enterovirus-induced
gene expression profile is critical for human pancreatic islet
destruction. Diabetologia 2012; 55: 3273–3283.
Article  CAS  Google Scholar 
9. Ramesh A, Chhabra P, Brayman KL . Pancreatic islet
transplantation in type 1 diabetes mellitus: an update on
recent developments. Curr Diabetes Rev 2013; 9: 294–311.
Article  Google Scholar 
10. Barshes NR, Wyllie S, Goss JA . Inflammation-mediated
dysfunction and apoptosis in pancreatic islet transplantation:
implications for intrahepatic grafts. J Leukoc Biol 2005; 77:
587–597.
Article  CAS  Google Scholar 
11. Schwarznau A, Hanson MS, Sperger JM, Schram BR,
Danobeitia JS, Greenwood KK et al. IL-1beta receptor


blockade protects islets against pro-inflammatory cytokine
induced necrosis and apoptosis. J Cell Physiol 2009; 220: 341–
347.
Article  CAS  Google Scholar 
12. Barshes NR, Wyllie S, Goss JA . Inflammation-mediated
dysfunction and apoptosis in pancreatic islet transplantation:
implications for intrahepatic grafts. J Leukoc Biol 2005; 77:
587–597.
Article  CAS  Google Scholar 
13. Dinarello CA . Interleukin-1 in the pathogenesis and
treatment of inflammatory diseases. Blood 2011; 117: 3720–
3732.
Article  CAS  Google Scholar 
14. Arend WP . The balance between IL-1 and IL-1Ra in disease.
Cytokine Growth Factor Rev 2002; 13: 323–340.
Article  CAS  Google Scholar 
15. Akash MS, Rehman K, Sun H, Chen S . Sustained delivery of
IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-
rats. PloS ONE 2013; 8: e55925.
Article  CAS  Google Scholar 
16. Schwarznau A, Hanson MS, Sperger JM, Schram BR,
Danobeitia JS, Greenwood KK et al. IL-1beta receptor
blockade protects islets against pro-inflammatory cytokine
induced necrosis and apoptosis. J Cell Physiol 2009; 220: 341–
347.
Article  CAS  Google Scholar 
17. Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY,
Mandrup-Poulsen T . Sustained effects of interleukin-1
receptor antagonist treatment in type 2 diabetes. Diabetes
Care 2009; 32: 1663–1668.


Article  CAS  Google Scholar 
18. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA,
Seifert B et al. Interleukin-1-receptor antagonist in type 2
diabetes mellitus. N Engl J Med 2007; 356: 1517–1526.
Article  CAS  Google Scholar 
19. Arend WP, Malyak M, Guthridge CJ, Gabay C . Interleukin-1
receptor antagonist: role in biology. Annu Rev Immunol 1998;
16: 27–55.
Article  CAS  Google Scholar 
20. Glas R, Sauter NS, Schulthess FT, Shu L, Oberholzer J,
Maedler K . Purinergic P2X7 receptors regulate secretion of
interleukin-1 receptor antagonist and beta cell function and
survival. Diabetologia 2009; 52: 1579–1588.
Article  CAS  Google Scholar 
21. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T
et al. Leptin modulates beta cell expression of IL-1 receptor
antagonist and release of IL-1beta in human islets. Proc Natl
Acad Sci USA 2004; 101: 8138–8143.
Article  CAS  Google Scholar 
22. Smith MF, Jr ., Eidlen D, Brewer MT, Eisenberg SP, Arend
WP, Gutierrez-Hartmann A. Human IL-1 receptor antagonist
promoter. Cell type-specific activity and identification of
regulatory regions. J Immunol 1992; 149: 2000–2007.
CAS  PubMed  Google Scholar 
23. Andersson J, Bjork L, Dinarello CA, Towbin H, Andersson U .
Lipopolysaccharide induces human interleukin-1 receptor
antagonist and interleukin-1 production in the same cell. Eur
J Immunol 1992; 22: 2617–2623.
Article  CAS  Google Scholar 


24. Jenkins JK, Arend WP . Interleukin 1 receptor antagonist
production in human monocytes is induced by IL-1 alpha,
IL-3, IL-4 and GM-CSF. Cytokine 1993; 5: 407–415.
Article  CAS  Google Scholar 
25. Luhm J, Langenkamp U, Hensel J, Frohn C, Brand JM, Hennig
H et al. Beta-(1→3)-D-glucan modulates DNA binding of
nuclear factors kappaB, AT and IL-6 leading to an anti-
inflammatory shift of the IL-1beta/IL-1 receptor antagonist
ratio. BMC Immunol 2006; 7: 5.
Article  Google Scholar 
26. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N .
Absence of IL-1 receptor antagonist impaired wound healing
along with aberrant NF-kappaB activation and a reciprocal
suppression of TGF-beta signal pathway. J Immunol 2006;
176: 5598–5606.
Article  CAS  Google Scholar 
27. Smith MF Jr, Eidlen D, Arend WP, Gutierrez-Hartmann A .
LPS-induced expression of the human IL-1 receptor antagonist
gene is controlled by multiple interacting promoter elements.
J Immunol 1994; 153: 3584–3593.
CAS  PubMed  Google Scholar 
28. Lewis EC . Expanding the clinical indications for alpha1-
antitrypsin therapy. Mol Med 2012; 18: 957–970.
Article  CAS  Google Scholar 
29. Russi EW . Alpha-1 antitrypsin: now available, but do we
need it? Swiss Med Wkly 2008; 138: 191–196.
CAS  PubMed  Google Scholar 
30. Toso C, Serre-Beinier V, Emamaullee J, Merani S, Armanet M,
Wojtusciszyn A et al. The role of macrophage migration
inhibitory factor in mouse islet transplantation.


Transplantation 2008; 86: 1361–1369.
Article  CAS  Google Scholar 
31. Pott GB, Chan ED, Dinarello CA, Shapiro L . Alpha-1-
antitrypsin is an endogenous inhibitor of proinflammatory
cytokine production in whole blood. J Leukoc Biol 2009; 85:
886–895.
Article  CAS  Google Scholar 
32. Ozeri E, Mizrahi M, Shahaf G, Lewis EC . alpha-1 antitrypsin
promotes semimature, IL-10-producing and readily migrating
tolerogenic dendritic cells. J Immunol 2012; 189: 146–153.
Article  CAS  Google Scholar 
33. Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E et al.
Alpha-1-antitrypsin monotherapy reduces graft-versus-host
disease after experimental allogeneic bone marrow
transplantation. Proc Natl Acad Sci USA 2012; 109: 564–569.
Article  CAS  Google Scholar 
34. Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, Lewis EC
. alpha-1-antitrypsin gene delivery reduces inflammation,
increases T-regulatory cell population size and prevents islet
allograft rejection. Mol Med 2011; 17: 1000–1011.
Article  CAS  Google Scholar 
35. Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark
AA, Lewis EC et al. Sustained expression of circulating human
alpha-1 antitrypsin reduces inflammation, increases
CD4+FoxP3+ Treg cell population and prevents signs of
experimental autoimmune encephalomyelitis in mice. Metab
Brain Dis 2011; 26: 107–113.
Article  CAS  Google Scholar 
36. Toldo S, Seropian IM, Mezzaroma E, Van Tassell BW, Salloum
FN, Lewis EC et al. Alpha-1 antitrypsin inhibits caspase-1 and


protects from acute myocardial ischemia-reperfusion injury. J
Mol Cell Cardiol 2011; 51: 244–251.
Article  CAS  Google Scholar 
37. Wang Y, He Y, Abraham B, Rouhani FN, Brantly ML, Scott DE
et al. Cytosolic, autocrine alpha-1 proteinase inhibitor (A1PI)
inhibits caspase-1 and blocks IL-1beta dependent cytokine
release in monocytes. PloS ONE 2012; 7: e51078.
Article  CAS  Google Scholar 
38. Stoller JK, Aboussouan LS . A review of alpha1-antitrypsin
deficiency. Am J Respir Crit Care Med 2012; 185: 246–259.
Article  CAS  Google Scholar 
39. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM . alpha
1-antitrypsin enhances insulin secretion and prevents
cytokine-mediated apoptosis in pancreatic beta-cells. Islets
2010; 2: 185–189.
Article  Google Scholar 
40. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall
C, Atkinson M et al. Alpha1-antitrypsin protects beta-cells
from apoptosis. Diabetes 2007; 56: 1316–1323.
Article  CAS  Google Scholar 
41. Zhou X, Shapiro L, Fellingham G, Willardson BM, Burton GF .
HIV replication in CD4+ T lymphocytes in the presence and
absence of follicular dendritic cells: inhibition of replication
mediated by alpha-1-antitrypsin through altered
IkappaBalpha ubiquitination. J Immunol 2011; 186: 3148–
3155.
Article  CAS  Google Scholar 
42. Chan ED, Pott GB, Silkoff PE, Ralston AH, Bryan CL, Shapiro
L . Alpha-1-antitrypsin inhibits nitric oxide production. J
Leukoc Biol 2012; 92: 1251–1260.


Article  CAS  Google Scholar 
43. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C et al.
Alpha-1-antitrypsin and a broad spectrum metalloprotease
inhibitor, RS113456, have similar acute anti-inflammatory
effects. Lab Invest 2001; 81: 1119–1131.
Article  CAS  Google Scholar 
44. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW .
Antiinflammatory properties of hepatic acute phase proteins:
preferential induction of interleukin 1 (IL-1) receptor
antagonist over IL-1 beta synthesis by human peripheral
blood mononuclear cells. J Exp Med 1993; 178: 1629–1636.
Article  CAS  Google Scholar 
45. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL,
Churg A et al. alpha1-Antitrypsin monotherapy induces
immune tolerance during islet allograft transplantation in
mice. Proc Natl Acad Sci USA 2008; 105: 16236–16241.
Article  CAS  Google Scholar 
46. Mendez J, Stillman B . Chromatin association of human origin
recognition complex, cdc6, and minichromosome
maintenance proteins during the cell cycle: assembly of
prereplication complexes in late mitosis. Mol Cell Biol 2000;
20: 8602–8612.
Article  CAS  Google Scholar 
47. Pott GB, Chan ED, Dinarello CA, Shapiro L . Alpha-1-
antitrypsin is an endogenous inhibitor of proinflammatory
cytokine production in whole blood. J Leukoc Biol 2009; 85:
886–895.
Article  CAS  Google Scholar 
48. Tawara I, Sun Y, Lewis EC, Toubai T, Evers R, Nieves E et al.
Alpha-1-antitrypsin monotherapy reduces graft-versus-host
disease after experimental allogeneic bone marrow


transplantation. Proc Natl Acad Sci USA 2012; 109: 564–569.
Article  CAS  Google Scholar 
49. Kline JN, Fisher PA, Monick MM, Hunninghake GW .
Regulation of interleukin-1 receptor antagonist by Th1 and
Th2 cytokines. Am J Physiol 1995; 269: L92–L98.
CAS  PubMed  Google Scholar 
50. Marie C, Pitton C, Fitting C, Cavaillon JM . IL-10 and IL-4
synergize with TNF-alpha to induce IL-1ra production by
human neutrophils. Cytokine 1996; 8: 147–151.
Article  CAS  Google Scholar 
51. Jenkins JK, Malyak M, Arend WP . The effects of
interleukin-10 on interleukin-1 receptor antagonist and
interleukin-1 beta production in human monocytes and
neutrophils. Lymphokine Cytokine Res 1994; 13: 47–54.
CAS  PubMed  Google Scholar 
52. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S .
Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist
production from lipopolysaccharide-stimulated human
polymorphonuclear leukocytes by delaying mRNA
degradation. J Exp Med 1994; 179: 1695–1699.
Article  CAS  Google Scholar 
53. Tamassia N, Castellucci M, Rossato M, Gasperini S, Bosisio D,
Giacomelli M et al. Uncovering an IL-10-dependent NF-
kappaB recruitment to the IL-1ra promoter that is impaired in
STAT3 functionally defective patients. FASEB J 2010; 24:
1365–1375.
Article  CAS  Google Scholar 
54. Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark
AA, Lewis EC et al. Sustained expression of circulating human
alpha-1 antitrypsin reduces inflammation, increases


CD4+FoxP3+ Treg cell population and prevents signs of
experimental autoimmune encephalomyelitis in mice. Metab
Brain Dis 2011; 26: 107–113.
Article  CAS  Google Scholar 
55. Ozeri E, Mizrahi M, Shahaf G, Lewis EC . Alpha-1 antitrypsin
promotes semi-mature, interleukin-10-producing and readily
migrating tolerogenic dendritic cells. J Immunol 2012; 189:
146–153.
Article  CAS  Google Scholar 
56. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H et
al. Curative and beta cell regenerative effects of alpha1-
antitrypsin treatment in autoimmune diabetic NOD mice. Proc
Natl Acad Sci USA 2008; 105: 16242–16247.
Article  CAS  Google Scholar 
57. Goldstein S, Reddy P . Tolerance without toxicity? alpha1-
antitrypsin as a novel alternative to immunosuppression.
Expert Rev Clin Immunol 2012; 8: 397–399.
Article  CAS  Google Scholar 
58. Thoms HC, Loveridge CJ, Simpson J, Clipson A, Reinhardt K,
Dunlop MG et al. Nucleolar targeting of RelAp65 is regulated
by COMMD1-dependent ubiquitination. Cancer Res 2010; 70:
139–149.
Article  CAS  Google Scholar 
59. Makowiec F, Koveker G, Weber P, Jenss H, Starlinger M .
Crohn's disease: disease activity and recurrence following
surgery. Deut Med Wochenschr 1990; 115: 1659–1664.
German.
Article  CAS  Google Scholar 
60. Hochrainer K, Racchumi G, Zhang S, Iadecola C, Anrather J .
Monoubiquitination of nuclear RelA negatively regulates NF-


kappaB activity independent of proteasomal degradation. Cell
Mol Life Sci 2012; 69: 2057–2073.
Article  CAS  Google Scholar 
61. Nita IM, Serapinas D, Janciauskiene SM . alpha1-Antitrypsin
regulates CD14 expression and soluble CD14 levels in human
monocytes in vitro. Int J Biochem Cell Biol 2007; 39: 1165–
1176.
Article  CAS  Google Scholar 
Download references
Author information
Author notes
1. Avishag Abecassis and Ronen Schuster: These authors
contributed equally to this manuscript.
Authors and Affiliations
1. Department of Clinical Biochemistry and Pharmacology,
Faculty of Health Sciences, Ben-Gurion University of the
Negev, Be'er-Sheva, Israel
Avishag Abecassis, Ronen Schuster, Galit Shahaf, Eyal
Ozeri, Ross Green, David E Ochayon, Peleg Rider & Eli C
Lewis
Authors
1. Avishag Abecassis
View author publications
Search author on:PubMed Google Scholar
2. Ronen Schuster
View author publications


Search author on:PubMed Google Scholar
3. Galit Shahaf
View author publications
Search author on:PubMed Google Scholar
4. Eyal Ozeri
View author publications
Search author on:PubMed Google Scholar
5. Ross Green
View author publications
Search author on:PubMed Google Scholar
6. David E Ochayon
View author publications
Search author on:PubMed Google Scholar
7. Peleg Rider
View author publications
Search author on:PubMed Google Scholar
8. Eli C Lewis
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Eli C Lewis.
Rights and permissions
Reprints and permissions


About this article
Cite this article
Abecassis, A., Schuster, R., Shahaf, G. et al. α1-antitrypsin increases
interleukin-1 receptor antagonist production during pancreatic islet
graft transplantation. Cell Mol Immunol 11, 377–386 (2014).
https://doi.org/10.1038/cmi.2014.17
Download citation
•  Received: 21 January 2014
•  Revised: 20 February 2014
•  Accepted: 20 February 2014
•  Published: 07 April 2014
•  Issue date: July 2014
•  DOI: https://doi.org/10.1038/cmi.2014.17
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
•  adaptive immunity
•  inflammation


•  innate immunity
•  macrophages
•  tolerance
This article is cited by
•  Bile and urine peptide marker profiles: access
keys to molecular pathways and biological
processes in cholangiocarcinoma
○  Torsten Voigtländer
○  Jochen Metzger
○  Michael P. Manns
Journal of Biomedical Science (2020)
•  Review 2: Primary graft dysfunction after lung
transplant—pathophysiology, clinical
considerations and therapeutic targets
○  Zhaosheng Jin
○  Ka Chun Suen
○  Daqing Ma
Journal of Anesthesia (2020)
•  Immune protective effect of human alpha-1-
antitrypsin gene during β cell transplantation in
diabetic mice
○  Lu Yang
○  Yu-Ting Liao
○  Fu-Rong Li
Immunologic Research (2015)
 Access through your institution


Buy or subscribe
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Current issue
•  Collections
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  Open Access Fees and Funding
•  About the Editors
•  About the Partner
•  Editorial Board
•  Contact
•  For Advertisers
•  Subscribe
Publish with us
•  For Authors & Referees
•  Language editing services


•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Cellular & Molecular Immunology (Cell Mol Immunol)
ISSN 2042-0226 (online)
ISSN 1672-7681 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io


•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa


•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


